Publicaciones en colaboración con investigadores/as de Queen Mary University of London (72)

2024

  1. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee

    eClinicalMedicine, Vol. 69

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Author Correction: Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth (Nature Communications, (2020), 11, 1, (2810), 10.1038/s41467-020-16618-6)

    Nature Communications

  3. Community detection in empirical kinase networks identifies new potential members of signalling pathways

    PLoS Computational Biology, Vol. 19, Núm. 6

  4. Deletion of macrophage Gpr101 disrupts their phenotype and function dysregulating host immune responses in sterile and infectious inflammation

    Biochemical Pharmacology, Vol. 207

  5. Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics

    Biomedicine and Pharmacotherapy, Vol. 158

  6. Global distributions of age- and sex-related arterial stiffness: systematic review and meta-analysis of 167 studies with 509,743 participants

    eBioMedicine, Vol. 92

  7. Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

    Blood

2022

  1. Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer

    Science Advances, Vol. 8, Núm. 5

  2. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

    Histopathology, Vol. 81, Núm. 6, pp. 826-840

  3. Genetics of Transformed Follicular Lymphoma

    Hemato, Vol. 3, Núm. 4, pp. 615-633

  4. Implementation of Clinical Phosphoproteomics and Proteomics for Personalized Medicine

    Methods in Molecular Biology (Humana Press Inc.), pp. 87-106

  5. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

    Annals of Oncology, Vol. 33, Núm. 3, pp. 259-275

  6. Plasmolipin regulates basolateral-to-apical transcytosis of ICAM-1 and leukocyte adhesion in polarized hepatic epithelial cells

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 1

  7. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

    The Lancet. Haematology, Vol. 9, Núm. 5, pp. e374-e384

  8. Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment

    Science Signaling, Vol. 15, Núm. 730

  9. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    Blood, Vol. 140, Núm. 11, pp. 1229-1253

  10. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes

    Nature Communications, Vol. 13, Núm. 1

  11. eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors

    Molecular and Cellular Proteomics, Vol. 21, Núm. 7

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1